Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
      Description

      The purpose of this study is to examine the degree to which pulmonary embolism (clot) can be dissolved when treated with a very low dose of a systemic thrombolytic drug (clot buster) along with standard anticoagulant therapy as compared to the standard of care anticoagulant therapy alone.

      Conditions
      Pulmonary Embolism With Acute Cor PulmonalePulmonary EmbolismPulmonary Embolism With Pulmonary InfarctionPulmonary Embolism Subacute MassiveRight Ventricular DysfunctionRight Ventricular Failure
      Talk to us